Sucralfate is a prescription medicine used to treat ulcers of the upper gastrointestinal tract, peptic ulcer disease, and to prevent reoccurrence of ulcers.
Growing incidence of gastric ulcers caused due to use of nonsteroidal anti-Inflammatory drugs (NSAID) and H. pylori infection is driving the U.S. sucralfate market. According to the study by Deccan College of Medical Sciences, 2016, an estimated 95% of duodenal and 70% of gastric ulcers are caused due to Helicobacter pylori. Furthermore, the same study also stated that around 14-25% of gastric and duodenal ulcers are associated with NSAID use.
The U.S. sucralfate market size was valued at US$ 296.2 million in 2021, and is expected to exhibit a CAGR of 3.1% over the forecast period (2022–2028).
Get Free Sample PDF Copy (Including Full TOC, List of Tables & Figures, Chart) @
Increasing prevalence of peptic ulcers is augmenting the market growth. According to the data published by ScienceDirect Journal in 2020, duodenal ulcers are more common type of peptic ulcers and its prevalence was around 6% to 12% in the U.S.
Increasing inorganic growth strategies such as collaboration and acquisitions by market players is expected to augment market growth. For instance, in 2019, Aptalis Pharma Inc., a specialty pharmaceutical company and manufacturer of Carafate, was acquired by Forest Laboratories, Inc., a fully integrated, specialty pharmaceutical company. Forest agreed to acquire Aptalis from TPG, the global private investment firm, for US$ 2.9 billion in cash.
Growing applications and uses of sucralfate in the U.S. is driving the market growth. According to the American Broncho Esophagological Association report, in April 2018, use of sucralfate along with honey aids in treatment of esophageal injury in infants and children. Esophageal injury in infants and children are associated with consumption of Button Batteries (BB), small disc-shaped batteries commonly found in toys.
Moreover, growing prevalence of gastro-esophageal reflux disease (GERD) and Helicobacter pylori infection is projected to bolster the U.S. sucralfate market over the forecast period. For instance, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the prevalence of GERD was reported in the range from 15% to 30% in the U.S. in 2014. Similarly, according to the data published in American Gastroenterological Association (AGA) Journal in 2017, the prevalence of Helicobacter pylori positive infection is 35.6% among the population in the U.S.
Request PDF Brochure with Latest Insights @
Major players operating in the U.S. sucralfate market include Teva Pharmaceutical Industries Ltd., Allergan plc, Vertice Pharma LLC, and Pharmaceutical Associates Inc.
Reasons to buy this U.S. Sucralfate Market Report
◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging U.S. Sucralfate Market
◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging U.S. Sucralfate Market
◘ Leading company profiles reveal details of key U.S. Sucralfate Market players emerging five operations and financial performance
◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging U.S. Sucralfate Market with five year historical forecasts
◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of U.S. Sucralfate Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of U.S. Sucralfate Market are also given.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 U.S. Sucralfate Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: U.S. Sucralfate Industry Impact
Chapter 2 Global U.S. Sucralfate Competition by Types, Applications, and Top Regions and Countries
2.1 Global U.S. Sucralfate (Volume and Value) by Type
2.3 Global U.S. Sucralfate (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global U.S. Sucralfate Sales, Consumption, Export, Import by Regions
Chapter 5 North America U.S. Sucralfate Market Analysis
Chapter 6 East Asia U.S. Sucralfate Market Analysis
Chapter 7 Europe U.S. Sucralfate Market Analysis
Chapter 8 South Asia U.S. Sucralfate Market Analysis
Chapter 9 Southeast Asia U.S. Sucralfate Market Analysis
Chapter 10 Middle East U.S. Sucralfate Market Analysis
Chapter 11 Africa U.S. Sucralfate Market Analysis
Chapter 12 Oceania U.S. Sucralfate Market Analysis
Chapter 13 South America U.S. Sucralfate Market Analysis
Chapter 14 Company Profiles and Key Figures in U.S. Sucralfate Business
Chapter 15 Global U.S. Sucralfate Market Forecast (2022-2028)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027